Cardio Diagnostics Holdings, Inc. (CDIO)
1.67
+0.02
(+1.21%)
USD |
NASDAQ |
Nov 20, 09:49
Cardio Diagnostics Holdings Free Cash Flow : -6.032M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -6.032M |
| June 30, 2026 | -6.106M |
| March 31, 2026 | -6.324M |
| December 31, 2025 | -6.146M |
| September 30, 2025 | -6.153M |
| June 30, 2025 | -5.738M |
| March 31, 2025 | -5.542M |
| December 31, 2024 | -5.397M |
| September 30, 2024 | -6.203M |
| Date | Value |
|---|---|
| June 30, 2024 | -6.077M |
| March 31, 2024 | -6.046M |
| December 31, 2023 | -6.445M |
| September 30, 2023 | -7.319M |
| June 30, 2023 | -7.630M |
| March 31, 2023 | -6.666M |
| December 31, 2022 | -5.167M |
| September 30, 2022 | -2.739M |
| June 30, 2022 | -1.283M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tenax Therapeutics, Inc. | -49.35M |
| Exicure, Inc. | -6.385M |
| Century Therapeutics, Inc. | -85.06M |
| Absci Corp. | -112.46M |
| Celularity, Inc. | -8.923M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.516M |
| Cash from Investing (Quarterly) | -0.0605M |
| Cash from Financing (Quarterly) | -0.0674M |
| Free Cash Flow Per Share (Quarterly) | -0.5327 |
| Free Cash Flow to Equity (Quarterly) | -1.446M |
| Free Cash Flow to Firm (Quarterly) | -1.574M |
| Free Cash Flow Yield | -122.0% |